Exagen Inc. (NASDAQ: XGN) Stock Information | RedChip

Exagen Inc. (NASDAQ: XGN)


$5.0000
-0.0200 ( -1.96% ) 65.8K

Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.

Market Data


Open


$5.0000

Previous close


$5.0200

Volume


65.8K

Market cap


$88.54M

Day range


$4.7480 - $5.2200

52 week range


$1.3003 - $6.2200

SEC Filings


Form Type Description Pages Date
8-k 8K-related 15 May 13, 2024
ars Annual reports 1 Apr 26, 2024
8-k 8K-related 14 Apr 26, 2024
def Proxies and info statements 4 Apr 26, 2024
10-k Annual reports 82 Mar 18, 2024
8-k 8K-related 15 Mar 18, 2024
4 Insider transactions 1 Mar 06, 2024
4 Insider transactions 1 Mar 04, 2024
4 Insider transactions 1 Feb 22, 2024
4 Insider transactions 1 Feb 22, 2024

Latest News